Handelsbanken Fonder AB’s Thermo Fisher Scientific Inc Position
Does Handelsbanken Fonder AB own Thermo Fisher Scientific Inc (TMO)? Yes — 634.8K shares worth $312M (+1.04% of its 13F portfolio) as of Q1 2026, down from 715.5K shares the prior filed quarter.
Position Value
$312M
Q1 2026
Shares
634.8K
% of Portfolio
+1.04%
Quarters Held
29
currently held
Position History TMO
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 634.8K | $312M | +1.04% |
| Q4 2025 | 715.5K | $415M | +1.25% |
| Q3 2025 | 703.1K | $341M | +1.08% |
| Q2 2025 | 501.1K | $203M | +0.72% |
| Q1 2025 | 393.5K | $196M | +0.81% |
| Q4 2024 | 374.2K | $195M | +0.74% |
| Q3 2024 | 393.0K | $243M | +0.96% |
| Q2 2024 | 390.7K | $216M | +0.94% |
| Q1 2024 | 411.4K | $239M | +1.03% |
| Q4 2023 | 405.6K | $215M | +1.05% |
| Q3 2023 | 354.1K | $179M | +1.00% |
| Q2 2023 | 378.1K | $197M | +1.06% |
| Q1 2023 | 468.0K | $270M | +1.56% |
| Q4 2022 | 440.4K | $243M | +1.52% |
| Q3 2022 | 441.1K | $224M | +1.50% |
| Q2 2022 | 424.2K | $230M | +1.50% |
| Q1 2022 | 386.3K | $228M | +1.27% |
| Q4 2021 | 388.0K | $259M | +1.27% |
| Q3 2021 | 371.5K | $212M | +1.11% |
| Q2 2021 | 394.8K | $199M | +1.04% |
| Q1 2021 | 408.6K | $186M | +1.06% |
| Q4 2020 | 398.5K | $186M | +1.13% |
| Q3 2020 | 396.6K | $175M | +1.28% |
| Q2 2020 | 786.5K | $285M | +1.21% |
| Q1 2020 | 336.2K | $95M | +2.05% |
| Q4 2019 | 354.3K | $115M | +1.99% |
| Q3 2019 | 351.0K | $102M | +2.07% |
| Q2 2019 | 345.7K | $102M | +1.88% |
| Q1 2019 | 361.4K | $99M | +1.92% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Handelsbanken Fonder AB’s full portfolio or all institutional holders of TMO.